Tarun Puri

1.5k total citations · 1 hit paper
62 papers, 886 citations indexed

About

Tarun Puri is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Tarun Puri has authored 62 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 13 papers in Surgery. Recurrent topics in Tarun Puri's work include Lung Cancer Treatments and Mutations (26 papers), Glioma Diagnosis and Treatment (12 papers) and Colorectal Cancer Treatments and Studies (12 papers). Tarun Puri is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Glioma Diagnosis and Treatment (12 papers) and Colorectal Cancer Treatments and Studies (12 papers). Tarun Puri collaborates with scholars based in India, United States and South Korea. Tarun Puri's co-authors include Shikha Goyal, Pramod Kumar Julka, Mauro Orlando, James Chih‐Hsin Yang, Chitra Sarkar, Jin Hyoung Kang, Keunchil Park, Joo-Hang Kim, Jianxing He and Haruyasu Murakami and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Tarun Puri

60 papers receiving 869 citations

Hit Papers

Selpercatinib in Patients With RET Fusion–Positive Non–Sm... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
    2022 119 citations Alexander Drilon, Vivek Subbiah et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarun Puri India 17 503 411 226 182 145 62 886
Preston D. Steen United States 18 329 0.7× 579 1.4× 259 1.1× 103 0.6× 129 0.9× 47 1.0k
Riki Okita Japan 20 395 0.8× 621 1.5× 205 0.9× 153 0.8× 133 0.9× 79 1.2k
Ching-Liang Ho Taiwan 13 451 0.9× 475 1.2× 251 1.1× 110 0.6× 89 0.6× 27 923
Chueh‐Chuan Yen Taiwan 19 377 0.7× 386 0.9× 203 0.9× 69 0.4× 73 0.5× 58 930
Keita Kudo Japan 13 611 1.2× 1.0k 2.5× 173 0.8× 59 0.3× 107 0.7× 35 1.3k
Jia Luo United States 15 458 0.9× 528 1.3× 328 1.5× 45 0.2× 288 2.0× 64 1.0k
Lawrence Garbo United States 15 188 0.4× 427 1.0× 311 1.4× 69 0.4× 84 0.6× 35 741
E. Joosens Belgium 11 173 0.3× 258 0.6× 133 0.6× 225 1.2× 72 0.5× 26 587
Ramón Palmero Spain 14 328 0.7× 384 0.9× 159 0.7× 49 0.3× 79 0.5× 50 646
L. Austin Doyle United States 12 200 0.4× 407 1.0× 338 1.5× 148 0.8× 108 0.7× 35 922

Countries citing papers authored by Tarun Puri

Since Specialization
Citations

This map shows the geographic impact of Tarun Puri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarun Puri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarun Puri more than expected).

Fields of papers citing papers by Tarun Puri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarun Puri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarun Puri. The network helps show where Tarun Puri may publish in the future.

Co-authorship network of co-authors of Tarun Puri

This figure shows the co-authorship network connecting the top 25 collaborators of Tarun Puri. A scholar is included among the top collaborators of Tarun Puri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarun Puri. Tarun Puri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ying, Herbert H. Loong, Caicun Zhou, et al.. (2024). Efficacy and safety of 1L selpercatinib in RET fusion-positive NSCLC: LIBRETTO-431 East Asian subgroup analysis.. Journal of Clinical Oncology. 42(23_suppl). 214–214. 1 indexed citations
2.
Pérol, M., Kōichi Goto, Benjamin Solomon, et al.. (2024). Intracranial outcomes of 1L selpercatinib in advanced RET fusion-positive NSCLC: LIBRETTO-431 study.. Journal of Clinical Oncology. 42(16_suppl). 8547–8547.
3.
Pérol, M., Benjamin Solomon, Kōichi Goto, et al.. (2024). CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non–Small Cell Lung Cancer. Journal of Clinical Oncology. 42(21). 2500–2505. 5 indexed citations
4.
Goto, Keiko, Benjamin Solomon, K. Park, et al.. (2023). LBA4 Randomized phase III study of first-line selpercatinib versus chemotherapy and pembrolizumab in RET fusion-positive NSCLC. Annals of Oncology. 34. S1303–S1303. 4 indexed citations
5.
Novello, Silvia, et al.. (2023). RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape. The Oncologist. 28(5). 402–413. 21 indexed citations
6.
7.
8.
Drilon, Alexander, Vivek Subbiah, Oliver Gautschi, et al.. (2022). Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial. Journal of Clinical Oncology. 41(2). 385–394. 119 indexed citations breakdown →
9.
Yang, James Chih‐Hsin, Ying Cheng, Haruyasu Murakami, et al.. (2019). A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis. Journal of Thoracic Oncology. 15(1). 91–100. 31 indexed citations
10.
Yang, James Chih‐Hsin, Haruyasu Murakami, Pan‐Chyr Yang, et al.. (2018). Gefitinib with or without pemetrexed in nonsquamous (NS) non-small cell lung cancer (NSCLC) with EGFR mutation (mut): Final overall survival (OS) results from a randomized phase II study. Annals of Oncology. 29. viii495–viii496. 7 indexed citations
11.
12.
Goyal, Shikha, et al.. (2015). Holocord low grade astrocytoma – Role of radical irradiation and chemotherapy. Journal of the Egyptian National Cancer Institute. 27(2). 105–108. 9 indexed citations
13.
Goyal, Shikha, Tarun Puri, & Pramod Kumar Julka. (2014). Breast cancer with inguinal node recurrence. Journal of the Egyptian National Cancer Institute. 27(1). 41–43. 2 indexed citations
14.
15.
Biswas, Ahitagni, Tarun Puri, Shikha Goyal, et al.. (2009). Spinal Myxopapillary Ependymoma With Down Syndrome: Exploring an Unusual Association. Journal of Pediatric Hematology/Oncology. 32(1). e38–e41. 5 indexed citations
16.
Biswas, Ahitagni, Tarun Puri, Shikha Goyal, et al.. (2009). Spinal intradural primary germ cell tumour—review of literature and case report. Acta Neurochirurgica. 151(3). 277–284. 15 indexed citations
17.
Goyal, Shikha, et al.. (2008). Accessory breast tissue in axilla masquerading as breast cancer recurrence. Journal of Cancer Research and Therapeutics. 4(2). 95–95. 18 indexed citations
18.
Biswas, Ahitagni, Tarun Puri, Shikha Goyal, et al.. (2008). Osseous Hodgkin's lymphoma—review of literature and report of an unusual case presenting as a large ulcerofungating sternal mass. Bone. 43(3). 636–640. 14 indexed citations
19.
Puri, Tarun, et al.. (2007). Long‐term clinical remission following radiotherapy in tracheal adenocarcinoma: Review of the published work. Australasian Radiology. 51(5). 485–488. 2 indexed citations
20.
Puri, Tarun, et al.. (2006). Extensive bone metastases from basal cell carcinoma of the eye.. PubMed. 47(9). 811–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Preston D. Steen Breakdown of academic impact, for papers by Riki Okita Breakdown of academic impact, for papers by Ching-Liang Ho Breakdown of academic impact, for papers by Chueh‐Chuan Yen Breakdown of academic impact, for papers by Keita Kudo Breakdown of academic impact, for papers by Jia Luo Breakdown of academic impact, for papers by Lawrence Garbo Breakdown of academic impact, for papers by E. Joosens Breakdown of academic impact, for papers by Ramón Palmero Breakdown of academic impact, for papers by L. Austin Doyle
Rankless by CCL
2026